[4] Therefore, direct pharmacokinetic interactions between berberine and semaglutide are unlikely
One subsequent analysis has estimated that 7.9 million individuals meet the SELECT trial criteria in the US: Among these individuals, treatment with semaglutide could prevent about 190 000 cardiovascular events in 5 years. If each eligible patient received semaglutide at a retail price of $16 188 per year, the total cost would amount to $127 billion per year. The authors of SELECT noted that: Potentially less costly alternatives for reducing obesity and CVD risk include lifestyle counseling, dietary fasting, and alternative pharmacological weight loss approaches
References: John P H Wilding, Rachel L Batterham, Salvatore Calanna, Melanie Davies, Luc F Van Gaal, Ildiko Lingvay, Barbara M McGowan, Julio Rosenstock, Marie T D Tran, Thomas A Wadden, Sean Wharton, Koutaro Yokote, Niels Zeuthen, Robert F Kushner
Brain Health Memory Plus by Qunol purportedly "supports your brain health for a sharper mind as you age." But does this formulation, or its ingredients, work and is it worth its price
Cardiovascular risk factors and future risk of Alzheimers disease
GLP-1 Agonist FAQs What are GLP-1 agonists and how do they work
